Search Results - jaehyun+kim

4 Results Sort By:
MTHFD2-Targeting Peptide Decoy for Chemotherapy-Resistant Cancers
Application An engineered decoy peptide, DMp39, targeting DLAT-MTHFD2 interaction, as a sensitizer for chemotherapy resistant cancer treatment. Key Benefits Restores chemotherapy sensitivity in resistant tumors. Targets the DLAT-MTHFD2 pathway with high specificity and minimal off-target toxicity. Market Summary Chemotherapy resistance remains...
Published: 6/22/2026   |   Updated: 6/15/2026   |   Inventor(s): Sumin Kang, Jung Seok Hwang, Jaehyun Kim
Keywords(s): Oncology Treatments, Protein and Peptide Therapeutics, Therapeutics
Category(s): TechPub Algolia > Therapeutics
Adhesive Microparticle Formulation For Localized And Sustained Drug Delivery
A hairy, water-in-oil-in-water microemulsion for prolonged delivery of one or more active ingredients while adhering to target tissues. Problem: Microparticles are promising drug delivery platforms due to their biocompatibility and stability. However, existing particle-based drug delivery systems are unable to fulfill the needs for prolonged delivery...
Published: 10/3/2025   |   Updated: 11/13/2024   |   Inventor(s): Daeyeon Lee, Minjun Oh, Jaehyun Kim, Li-Wei Chang, Robert Mauck, George Dodge, Hyun (Michel) Koo
Keywords(s): Bioengineering, Dentistry, Drug Delivery, Drug Target
Category(s): Technology Classifications > Materials
Nandrolone 17 Beta-Carbonates
Summary: Researchers at the Eunice Kennedy Shriver National Institute of Child Health and Human Development are highly motivated in seeking licensing and/or collaboration partners for the development and use of androgenic compounds as contraceptives and/or hormonal therapeutics. Description of Technology: The available options for male contraceptives...
Published: 4/23/2026   |   Updated: 8/2/2023   |   Inventor(s): Richard Blye, Hyun Kim, Min Lee
Keywords(s): 19-nortestosterone, Androgenic Compounds, Blye, Male Contraceptive, Nandrolone, National Institute of Child Health and Human Development, NICHD
Category(s): TherapeuticArea > Endocrinology, Collaboration Sought > Licensing, Application > Therapeutics, Collaboration Sought > Collaboration, TherapeuticArea > Reproductive Health
Cell-free RNA biomarkers capable of distinguishing cancer from premalignant disease
Summary Early cancer detection is critical for improving long-term patient survival and highlights a need for new sensitive and minimally-invasive early detection methods. The current technology includes novel sets of cell-free RNA biomarkers that can be used to potentially distinguish between malignant and pre-malignant forms of certain cancers using...
Published: 6/15/2022   |   Updated: 5/9/2022   |   Inventor(s): Thuy Ngo, Hyun Kim, Josiah Wagner, Breeshey Roskams-Hieter, Pavana Anur
Keywords(s): Diagnostics, Diagnostics - Cancer
Category(s): Diagnostics